🔎 Trials Near Me

Hjem › Pladecellekarcinom › Tennessee

Pladecellekarcinom kliniske forsøg i Tennessee

7 studier for Pladecellekarcinom søger deltagere på steder i Tennessee.

Byer i Tennessee

Officiel studietekst (engelsk)

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

  • Vanderbilt University Medical Center, Nashville
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 24. sep. 2026 · NCT06047379

A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors

  • Sarah Cannon Research Institute, Nashville
  • SCRI Oncology Partners, Nashville
  • Vanderbilt-Ingram Cancer Center, Nashville
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 8. sep. 2026 · NCT06561685

Window Trial of Fluorescently Labeled Panitumumab (Panitumumab-IRDye800) in Head and Neck Cancer

  • Vanderbilt University Medical Center, Nashville
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 3. aug. 2026 · NCT06819228

Safety and Feasibility of Nivolumab-IRDye800CW in Patients With Head and Neck Squamous Cell Carcinoma (HNSCC)

  • Vanderbilt University Medical Center, Nashville
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 7. jul. 2026 · NCT07460765

Study Evaluating [18F]NOTA-ABY030 for Safety and Tolerability of Indeterminate Primary and/or Metastatic Disease in Head and Neck Squamous Cell Carcinoma

  • Vanderbilt University Medical Center, Nashville
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 11. maj 2026 · NCT07217028

High-Resolution PET-CT Imaging for Surgical Margin Visualization

  • Vanderbilt University Medical Center, Nashville
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 8. maj 2026 · NCT06915454

Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors

  • Vanderbilt University Medical Center, Nashville
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 15. aug. 2025 · NCT04429542

Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.